ULMA Medical Technologies

ULMA Medical Technologies focuses on developing diagnostics and data analysis solutions using artificial intelligence to enhance healthcare quality and accessibility. As part of the ULMA Group, the company offers a scalable web platform called UMI, which serves a variety of healthcare providers, from large hospitals to small clinics. UMI streamlines diagnostic and monitoring processes by integrating tools for data analysis and automatic clinical report generation, all through an intuitive interface. One of the company's key products is UMI DR, an AI-powered software for screening diabetic retinopathy, which has received CE Marking certification under the EU’s medical device regulation. This certification allows ULMA to market UMI DR across the EU and internationally, and the solution is already being supplied to notable healthcare entities. ULMA Medical Technologies is also developing AI-based diagnostic solutions for other ophthalmological conditions, such as glaucoma and macular degeneration, and is expanding into dermatology and cardiology. The company values a people-centered culture, emphasizing innovation and the expertise of its multidisciplinary team.

• Employees 10